The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ruth D. Etzioni

Program in Biostatistics

Division of Public Health Sciences

Fred Hutchinson Cancer Research Center

Seattle

USA

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Program in Biostatistics, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA. 2012
  • Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. 1999 - 2008
  • Translational and Outcomes Research Group, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M2-B230, USA. 2003 - 2007

References

  1. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Etzioni, R., Mucci, L., Chen, S., Johansson, J.E., Fall, K., Adami, H.O. Clin. Cancer Res. (2012) [Pubmed]
  2. The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines. Etzioni, R., Gulati, R., Tsodikov, A., Wever, E.M., Penson, D.F., Heijnsdijk, E.A., Katcher, J., Draisma, G., Feuer, E.J., de Koning, H.J., Mariotto, A.B. Cancer (2012) [Pubmed]
  3. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., DiTommaso, D., Karnofski, K., Gulati, R., Penson, D.F., Feuer, E. Cancer. Causes. Control (2008) [Pubmed]
  4. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Etzioni, R., Gulati, R., Falcon, S., Penson, D.F. Med. Decis. Making (2008) [Pubmed]
  5. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. Etzioni, R.D., Ankerst, D.P., Weiss, N.S., Inoue, L.Y., Thompson, I.M. J. Natl. Cancer Inst. (2007) [Pubmed]
  6. Analyzing patterns of staining in immunohistochemical studies: application to a study of prostate cancer recurrence. Etzioni, R., Hawley, S., Billheimer, D., True, L.D., Knudsen, B. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  7. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. Etzioni, R.D., Howlader, N., Shaw, P.A., Ankerst, D.P., Penson, D.F., Goodman, P.J., Thompson, I.M. J. Urol. (2005) [Pubmed]
  8. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?. Etzioni, R., Falcon, S., Gann, P.H., Kooperberg, C.L., Penson, D.F., Stampfer, M.J. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  9. The case for early detection. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., Hartwell, L. Nat. Rev. Cancer (2003) [Pubmed]
  10. Combining biomarkers to detect disease with application to prostate cancer. Etzioni, R., Kooperberg, C., Pepe, M., Smith, R., Gann, P.H. Biostatistics (2003) [Pubmed]
  11. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. Etzioni, R., Penson, D.F., Legler, J.M., di Tommaso, D., Boer, R., Gann, P.H., Feuer, E.J. J. Natl. Cancer Inst. (2002) [Pubmed]
  12. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. Etzioni, R., Legler, J.M., Feuer, E.J., Merrill, R.M., Cronin, K.A., Hankey, B.F. J. Natl. Cancer Inst. (1999) [Pubmed]
 
WikiGenes - Universities